| 22.18 6.41 (40.65%) | 11-04 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 27.79 |
1-year : | 32.46 |
| Resists | First : | 23.79 |
Second : | 27.79 |
| Pivot price | 15.45 |
|||
| Supports | First : | 17.42 |
Second : | 13.47 |
| MAs | MA(5) : | 16.65 |
MA(20) : | 15.22 |
| MA(100) : | 12.58 |
MA(250) : | 13.89 |
|
| MACD | MACD : | 0.9 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 71.9 |
D(3) : | 69.6  |
| RSI | RSI(14): 91.3 |
|||
| 52-week | High : | 23.79 | Low : | 8.6 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ TCMD ] has closed above the upper band by 42.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 358.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 23.84 - 23.93 | 23.93 - 24.03 |
| Low: | 20.55 - 20.64 | 20.64 - 20.73 |
| Close: | 22.03 - 22.19 | 22.19 - 22.36 |
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Tue, 04 Nov 2025
Tactile Systems Technology Analysts Increase Their Forecasts After Better-Than-Expected Q3 Earnings - Benzinga
Tue, 04 Nov 2025
Tactile Systems (TCMD) Q3 2025 Earnings Transcript - The Motley Fool
Tue, 04 Nov 2025
TCMD: BTIG Upgrades Tactile Systems Tech to Buy with a $28 Targe - GuruFocus
Tue, 04 Nov 2025
Tactile Systems stock rating upgraded to Buy by BTIG on strong results - Investing.com
Tue, 04 Nov 2025
Tactile Systems Technology Inc (TCMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance
Mon, 03 Nov 2025
Tactile Systems Technology Posts Strong Quarter With Upbeat Guidance - Finimize
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 22 (M) |
| Shares Float | 20 (M) |
| Held by Insiders | 2.7 (%) |
| Held by Institutions | 100.4 (%) |
| Shares Short | 1,940 (K) |
| Shares Short P.Month | 2,070 (K) |
| EPS | 0.62 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.73 |
| Profit Margin | 5 % |
| Operating Margin | 5.1 % |
| Return on Assets (ttm) | 4.2 % |
| Return on Equity (ttm) | 7.6 % |
| Qtrly Rev. Growth | 7.8 % |
| Gross Profit (p.s.) | 10.01 |
| Sales Per Share | 13.4 |
| EBITDA (p.s.) | 1.15 |
| Qtrly Earnings Growth | -22.7 % |
| Operating Cash Flow | 42 (M) |
| Levered Free Cash Flow | 36 (M) |
| PE Ratio | 35.77 |
| PEG Ratio | 0 |
| Price to Book value | 2.53 |
| Price to Sales | 1.65 |
| Price to Cash Flow | 11.83 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|